Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection, By Application, By Region & Competition, 2020-2030F

Description

The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 4.66 Billion
Market Size 2030	USD 6.95 Billion
CAGR 2025-2030	7.02%
Fastest Growing Segment	Hyaluronic Acid Injections
Largest Market	North America

Key Market Drivers

Rising Obesity Rates

The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.

Key Market Challenges

Reimbursement Issues

Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.

Key Market Trends

Advancements in Biologics and Regenerative Therapies

Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.

Key Market Players

Anika Therapeutics Inc
Bioventus LLC
Ferring Pharmaceuticals Inc
Sanofi SA
Pfizer Inc
Eli Lilly & Co
Flexion Therapeutics Inc
Teva Pharmaceutical Industries Ltd
Zimmer Biomet Holdings, Inc.

Report Scope:

In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Joint Pain Injections Market, By Type of Injection:

Steroid Joint Injections
Hyaluronic Acid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Others

Joint Pain Injections Market, By Application:

Shoulder & Elbow
Knee & Ankle
Spinal Joints
Hip Joint
Others

Joint Pain Injections Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.

Available Customizations:

Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Joint Pain Injections Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map
- 5.3.1. By Type of Injection
- 5.3.2. By Application
- 5.3.3. By Region

6. North America Joint Pain Injections Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Joint Pain Injections Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type of Injection
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Joint Pain Injections Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type of Injection
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Joint Pain Injections Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type of Injection
    - 6.3.3.2.2. By Application

7. Europe Joint Pain Injections Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Joint Pain Injections Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type of Injection
    - 7.3.1.2.2. By Application
- 7.3.2. United Kingdom Joint Pain Injections Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type of Injection
    - 7.3.2.2.2. By Application
- 7.3.3. France Joint Pain Injections Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type of Injection
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Joint Pain Injections Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type of Injection
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Joint Pain Injections Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type of Injection
    - 7.3.5.2.2. By Application

8. Asia-Pacific Joint Pain Injections Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Joint Pain Injections Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type of Injection
    - 8.3.1.2.2. By Application
- 8.3.2. Japan Joint Pain Injections Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type of Injection
    - 8.3.2.2.2. By Application
- 8.3.3. India Joint Pain Injections Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type of Injection
    - 8.3.3.2.2. By Application
- 8.3.4. Australia Joint Pain Injections Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type of Injection
    - 8.3.4.2.2. By Application
- 8.3.5. South Korea Joint Pain Injections Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type of Injection
    - 8.3.5.2.2. By Application

9. South America Joint Pain Injections Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Joint Pain Injections Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type of Injection
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Joint Pain Injections Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type of Injection
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Joint Pain Injections Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type of Injection
    - 9.3.3.2.2. By Application

10. Middle East and Africa Joint Pain Injections Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
- 10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Joint Pain Injections Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type of Injection
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type of Injection
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Joint Pain Injections Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type of Injection
    - 10.3.3.2.2. By Application
- 10.3.4. Kuwait Joint Pain Injections Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Type of Injection
    - 10.3.4.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Anika Therapeutics Inc
14.2. Bioventus LLC
14.3. Ferring Pharmaceuticals Inc
14.4. Sanofi SA
14.5. Pfizer Inc
14.6. Eli Lilly & Co
14.7. Flexion Therapeutics Inc
14.8. Teva Pharmaceutical Industries Ltd
14.9. Zimmer Biomet Holdings, Inc.